LATEST FROM THE BLOG
Neurodevelopmental Outcomes in Kindergartners with Prenatal Exposure to Antidepressants
While we have data to support the use of antidepressants, including the selective serotonin reuptake [...]
Weekly Roundup for May 29, 2020: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health, covering topics related [...]
Virtual Rounds with the Center for Women’s Mental Health Extended through June!
Over the past two months, the MGH Center for Women's Mental Health has had the [...]
The National
Pregnancy Registry
for Psychiatric Medications:
All pregnant women between the ages of 18-45 with a history of psychiatric illness are eligible to enroll in the registry.
MGH Perinatal Depression Scale Mobile App
Are you pregnant? Do you own a smart phone? Get the MGH Perinatal Depression Scale app.
RESEARCH STUDIES
A Neurosteroid Intervention for Menopausal and Perimenopausal Depression
Are you experiencing symptoms of menopause and feeling depressed or down? You may be eligible for a research study at Massachusetts General Hospital evaluating how a medication treats menopausal depression and other symptoms of menopause.
National Pregnancy Registry for Psychiatric Medications©
The National Pregnancy Registry for Psychiatric Medications is dedicated to evaluating the safety of psychiatric medications such as antidepressants, stimulants, and atypical antipsychotics that many women take during pregnancy to treat a wide range of mood, anxiety, or psychiatric disorders.
TO PARTICIPATE CALL TOLL-FREE:
1-866-961-2388
MGH Postpartum Psychosis Project (MGHP3)
If you are a mother who has experienced an episode of postpartum psychosis within the past ten years, you could help us to better understand this disorder. Researchers at Massachusetts General Hospital’s (MGH) Ammon-Pinizzotto Center for Women’s Mental Health are announcing the launch of a new research study called the MGH Postpartum Psychosis Project (MGHP3).
UPWARD & UPWARD(S) – Preventing depressive relapse in pregnancy and the post-partum
People who have been depressed in the past are at risk of becoming depressed in the future, and depression during pregnancy is all too common. Our study seeks to determine whether a digital mindfulness-based cognitive therapy (MBCT) platform is effective in preventing depressive relapse during pregnancy and the post-partum period.
SPECIALTY AREAS
PMS & PMDD
When PMS symptoms interfere with functioning and quality of life
Fertility & Mental Health
Stress, depression, and anxiety associated with infertility and its treatment
Psychiatric Disorders During Pregnancy
Weighing the risks and benefits of pharmacologic treatment during pregnancy
Postpartum Psychiatric Disorders
Most women suffering from postpartum depression do not receive adequate care
Breastfeeding & Psychiatric Medications
How safe is it for women to take medications and breastfeed?
Menopausal Symptoms
Depression, hot flashes, sleep disturbance… What are safe treatment for symptomatic midlife women?
SUBSCRIBE TO OUR NEWSLETTER
Keep up with the latest news in women’s mental health and our research
FOR PATIENTS
